Mirian Brink

Mirian Brink

UNVERIFIED PROFILE

Are you Mirian Brink?   Register this Author

Register author
Mirian Brink

Mirian Brink

Publications by authors named "Mirian Brink"

Are you Mirian Brink?   Register this Author

13Publications

427Reads

31Profile Views

Adherence to cancer treatment guidelines: influence of general and cancer-specific guideline characteristics.

Eur J Public Health 2017 08;27(4):616-620

Netherlands Institute for Health Services Research (NIVEL), Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurpub/ckw234DOI Listing
August 2017

Doctors' reports about palliative systemic treatment: A medical record study.

Palliat Med 2017 03 19;31(3):239-246. Epub 2016 Aug 19.

1 Department of Registry and Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269216316661685DOI Listing
March 2017

Trends in incidence, primary treatment and survival in chronic myelomonocytic leukaemia: a population-based study of 1359 patients diagnosed in the Netherlands from 1989 to 2012.

Br J Haematol 2015 Nov 8;171(3):436-9. Epub 2015 Apr 8.

Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.13414
Publisher Site
http://dx.doi.org/10.1111/bjh.13414DOI Listing
November 2015

Markedly increased incidence and improved survival of testicular cancer in the Netherlands.

Acta Oncol 2014 Mar 30;53(3):342-50. Epub 2013 Aug 30.

Eindhoven Cancer Registry/Comprehensive Cancer Centre South , Eindhoven , The Netherlands.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/0284186X.2013.81
Publisher Site
http://dx.doi.org/10.3109/0284186X.2013.819992DOI Listing
March 2014

Prevalence of multiple malignancies in the Netherlands in 2007.

Int J Cancer 2011 Apr 25;128(7):1659-67. Epub 2010 May 25.

Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.25480DOI Listing
April 2011

Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes.

Cancer Causes Control 2007 Oct 18;18(8):865-79. Epub 2007 Jul 18.

Department of Epidemiology, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-007-9032-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2039842PMC
October 2007

Dietary folate intake and k-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study.

Int J Cancer 2005 May;114(5):824-30

Research Institute Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20775DOI Listing
May 2005

Fat and K-ras mutations in sporadic colorectal cancer in The Netherlands Cohort Study.

Carcinogenesis 2004 Sep 29;25(9):1619-28. Epub 2004 Apr 29.

Nutrition and Toxicology Research Institute Maastricht, Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgh177DOI Listing
September 2004

APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study.

Carcinogenesis 2004 Jul 19;25(7):1219-26. Epub 2004 Feb 19.

Nutrition and Toxicology Research Institute Maastricht, Department of Epidemiology, University Maastricht, 6200 MD Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgh117DOI Listing
July 2004

K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study.

Carcinogenesis 2003 Apr;24(4):703-10

Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Department of Epidemiology, Maastricht University, PO Box 616, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgg009DOI Listing
April 2003

K-ras mutations and RASSF1A promoter methylation in colorectal cancer.

Oncogene 2002 May;21(23):3792-5

Department of Pathology, University Maastricht, P.O. Box 616 6200 MD Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205466DOI Listing
May 2002